ABSTRACT Monospecific antibodies were prepared to a previously characterized chondroitin sulfate proteoglycan of brain and used in conjunction with the peroxidase-antiperoxidase technique to localize the proteoglycan by immunoelectron microscopy. The proteoglycan was found to be exclusively intracellular in adult cerebellum, cerebrum, brain stem, and spinal cord. Some neurons and astrocytes (including Golgi epithelial cells and Bergmann fibers) showed strong cytoplasmic staining. Although in the central nervous system there was heavy axoplasmic staining of many myelinated and unmyelinated fibers, not all axons stained. Staining was also seen in retinal neurons and glia (ganglion cells, horizontal cells, and M~iller cells), but several central nervous tissue elements were consistently unstained, including Purkinje cells, oligodendrocytes, myelin, optic nerve axons, nerve endings, and synaptic vesicles. In sympathetic ganglion and peripheral nerve there was no staining of neuronal cell bodies, axons, myelin, or Schwann cells, but in sciatic nerve the Schwann cell basal lamina was stained, as was the extracellular matrix surrounding collagen fibrils. Staining was also observed in connective tissue surrounding the trachea and in the lacunae of tracheal hyaline cartilage. These findings are consistent with immunochemical studies demonstrating that antibodies to the chondroitin sulfate proteoglycan of brain also cross-react to various degrees with certain connective tissue proteoglycans.
We have previously described the isolation and properties of a 6.5S chondroitin sulfate proteoglycan from a PBS extract of rat brain (19) . This proteoglycan has a relatively high protein content (56% by weight), in addition to 24% glycosaminoglycans (predominantly chondroitin 4-sulfate) and 20% glycoprotein oligosaccharides, including a series of novel O-glycosidically linked oligosaccharides that contain mannose at their proximal ends (16, 28) . The brain proteoglycan differs from the prototypical cartilage proteoglycans in a number of respects including its higher protein content, smaller monomer size, and its relatively limited ability to interact with hyaluronic acid to produce larger size aggregates.
Biochemical analyses (for reviews, see references 27 and 28) demonstrated the presence of significant amounts of chondroitin sulfate in neuronal cell bodies, axons, and astrocytes (isolated in bulk from brain) as well as in purified nuclei, whereas there is little or no chondroitin sulfate in oligodendroglia, myelin, mitochondria, or nerve endings (synaptosomes). Approximately half of the chondroitin sulfate is found in the soluble fraction after high speed centrifugation of a brain homogenate, and much of the remainder is loosely associated with microsomal membranes from which it is easily extractable by mild washing procedures (19, 29) .
When neurons are isolated in bulk from rat brain and lysed by a change in tonicity or pH, 82% of the chondroitin sulfate is released together with >90% of the lactate dehydrogenase (but only 20-25% of the total cell protein and glycoprotein hexosamine; 27). Since the chondroitin sulfate was not removed during the previous washing steps in the cell isolation procedure or by mild trypsinization of the purified neurons, we concluded that a significant portion of the chondroitin sulfate proteoglycan is present as a cytoplasmic (and axoplasmic) component of neurons. However, these biochemical analyses could not provide a very detailed picture of the distribution of chondroitin sulfate among various cell types and subcellular compartments, nor any information relevant to the postulated extracellular localization of chondroitin sulfate proteoglycans in nervous tissue. In the present immunocytochemical studies we have therefore utilized specific antibodies to the proteoglycan to investigate its cellular and tissue distribution at the light and electron microscopic levels, while an accompanying report (2) describes developmental changes in the localization of this proteoglycan in rat cerebellum.
M A T E R I A L S A N D M E T H O D S
Isolation of the Chondroitin Sulfate Proteoglycan: The proteoglycan was isolated as previously described (21) from a 140,000 g supernatant of adult rat brain (Sprague-Dawley) homogenized in 5 mM PBS, pH 7.2. The supernatant was dialyzed against deionized water, lyophilized, redissolved in 50 mM Tris-HCl buffer (pH 8.25 at 4"C) containing 90 mM NaCI, and applied to a column of DEAL-cellulose previously equilibrated with the same buffer. After stepwise elution with lower ionic strength buffers, the proteoglycan was eluted with 0.5 M NaCI in 50 mM Tris-HC1 buffer, pH 8.25. These fractions were pooled, dialyzed against deionized water, lyophilized, redissolved in 0.2 M sodium acetate buffer (pH 5.6), and eluted from a column of Scpharose CL-6B using the same buffer. The purified proteoglycan appeared in the void volume, well separated from a large retarded peak of protein and nucleic acid.
Preparation of IgC and F(ab')2:
The purified proteoglycan was dissolved at a concentration of 6.6 mg/ml (wt/vol) in 0.9% NaC1. 0.75 ml of this solution (5 mg of proteoglycan) was mixed with an equal volume of Freund's complete adjuvant (Difco Laboratories Inc., Detroit, MI) and emulsifted in an ice hath by probe sonication (10 W, 10 s bursts) until a drop of the emulsion remained undispersed in water. After a preimmune serum specimen was collected, female New Zealand White rabbits were immunized by injecting 0.75 ml of emulsion into each hind leg gluteal muscle. 2 wk after the initial immunization the rabbits were boosted with 2 mg proteoglycan (in 1.5 ml) injected as above. After an additional 2 wk rabbits were again boosted in the same way, except that one-quarter of the innoculum was injected into each thigh and one-half was injected subcutaneously in the interscapular region. 20 ml of blood was obtained from the auricular artery at I and 3 wk after the initial immunization, and rabbits were bled-out by cardiac puncture under anesthesia after a total of 5 wk. All serum samples were assayed for antibody titer.
IgG was precipitated from fresh or frozen serum by adding an equal volume of saturated ammonium sulfate at room temperature. After standing for 15 rain with occasional mixing, the serum was centrifuged at 25*(2 for 10 rain at 48,000 g. The pellet was resuspended in a minimal volume of 50 mM PBS (pH 7.2) containing 0.05% sodium azide, and dialyzed against the same buffer at 4"C.
For preparation of F(ab')2 fragments, the IgG solution was diluted to 25 mg IgG/ml with 0.2 M sodium acetate buffer (pH 4.0) containing 0.1% sodium azide, and dialyzed overnight against the same buffer at 4"C. (IgG concentration was calculated on the basis of E I~ at 280 nm = 14; reference 25). Pepsin (Worthington Biochemical Corp., Freehold, N J, twice crystallized) was added at a concentration of 0.02 mg/mg lgG, and the solution was stirred for ~24 h at 37"C. The digestion was terminated by adding Tris-base to pH 8.6, followed by stirring for ~20 min. The digest was then dialyzed at 4"C against 50 mM PBS, pH 7.2, containing 0.05% sodium azide, After concentration to 10 ml by pressure uitrafiltration (Amieon Corp., Scientific Systems Div., Danvers, MA, PM30 membrane), the digest was centrifuged for 1 h at 114,000 g, and the supernatant was applied to a column (2.5 x 93 cm) of Ultrogel AcA 44 (LKB Instruments, Inc., Gaithersburg, MD) previously equilibrated with 50 mM PBS (pH 7.2) at 4"C containing 0.05% sodium azide. 8-ml fractions were collected and monitored for absorbance at 280 nm.
Fractions containing F(ab')2 fragments were pooled, concentrated by pressure ultrafiltration, and further purified by affinity chromatography on a column of AH-Scpharose 4B (Pharmacia Inc., Piscataway, NJ) to which the purified brain proteoglycan had been coupled using the general procedure of Cambiaso et al. (9) . AH-Scpharose 4B was suspended in 50 mM boratephosphate buffer (pH 8.4) and washed six times, each time separating the washed beads by low speed centrifugation (600 g for l0 rain), l ml of 25% glutaraldehyde diluted with 6 ml of borate-phosphate buffer was added to 3 ml of Sepharose beads (packed by centrifugation). After 15 min of mixing on a Clay Adams Nutator (Clay Adams, Div, of Becton, Dickinson & Co., Parsippuny, NJ) at room temperature, the activated Sepharose was washed with the same buffer on a slntered glass filter funnel.
The chondroitin sulfate proteoglycan (1.8 mg protein/ml in borate-phosphate buffer) was centrifuged at 12,000 g for l0 rain, and the superuatant was added to an equal volume of packed AH-Sepharose 4B. This suspension was mixed for 1 h at room temperature, followed by -40 h at 4"C. The Sepharose was brought to room temperature, poured into a column (0.9 cm diam), and rinsed with distilled water until no protein was detectable by measuring the absorbance of the effluent at 280 nm. This was followed by additional rinses with 5, 100, and 5 mM Tris-HCl buffer (pH 7.6) containing 0.05% sodium azide. The Sepharose was finally washed with 0.01 M PBS, pH 7.2, containing 0.05% sodium azide. F(ab')2 fragments were diluted to 10 mg/ml with 50 mM PBS (pH 7.2) containing 0.05% sodium azide, and mixed with an equal volume of settled proteoglycan-Sepharose equilibrated with the same buffer. After ~48 h of mixing at 4"C, the Sepharose was warmed to room temperature and poured into a column (0.9 cm diam). Nonspecifically bound proteins were eluted by sequential rinses with 10 mM PBS (pH 7.2), 1 M NaCI containing 0.1% polyoxyethylene sorbitan monolaurate (Tween 20; Sigma Chemical Co., St. Louis, MO), and 10 mM PBS (pH 7.2), until no protein was detected by measuring the absorbance of the effluent at 280 nm. Specifically bound antibodies were eluted with 0.1 M glycine-HCl buffer (pH 3.0), immediately neutralized to pH 7.0-72 with 0.5 N NaOH, pooled, dialyzed at 4"C against 50 mM PBS (pH 7.2), and concentrated by pressure ultrafiltration. All buffers for affinity chromatography and dialysis contained 0.05% sodium azide.
Immunodiffusion and Immunoelectrophoresis: Immunogels were prepared with 0.7% (wt/vol) agarose in 10 mM PBS for immunodiffusion. Gels for immunoelectrophoresis contained 0.6% agarose, 90 mM Tris, 80 mM boric acid, 3 mM disodium EDTA, and 0.05% (wt/vol) sodium azide at pH 8.3. Antibody was added immediately before pouring plates at 52"C. Glass plates (previously coated with 0.2% agarose in distilled water containing 0.05% sodium azide) were usually coated with 0.2 ml of gel per square centimeter.
Immunodiffusion was for 24 h at room temperature in a humidified chamber. Immunoelectrophoresis (either Laurell or crossed) was at constant voltage as indicated in the figure legends. Plates were dried, washed in PBS and deionized water, and finally air-dried before staining with Coomassie Blue (38) . 5-~galiquots of the proteoglycan, dissolved in 10 mM PBS containing 0.05% sodium azide, were air-dried in wells of polystyrene microtiter plates (Dynatech Laboratories, Inc., Alexandria, VA: No. 01-010-2201). Unbound antigen was removed by washing the plates for 5 min with PBS containing 0.1% Tween 20. The wells were emptied by inverting the plates, and the washing procedure was repeated once. Residual buffer was aspirated from the wells using polyethylene tubing, after which 20 ul of antibody solution were added to the wells in doubling dilutions (in PBS containing 0.1% Tween 20)~ After standing for 15 rain at room temperature, the plates were washed twice for l rain with PBS containing 0.1% Tween 20. The buffer was then aspirated before adding 20 ~l of peroxidase-conjugated swine IgG anti-rabbit IgG (DAKO, Accurate Chemical and Scientific Corp., Westbury, NY) diluted 20-fold with PBS containing 0.1% Tween 20, or peroxidase-conjugated goat IgG anti-rabbit F(ab')2 (Cappel Laboratories, Cochranville, PA) diluted 320-fold. After standing for 15 rain at room temperature the plates were washed twice as before. The buffer was aspirated and 20 tA of phenylenediamine solution was added. The reaction was allowed to develop for 2 h at room temperature in a humidified chamber, after which it was terminated by the addition of 1.2 #l of 4 N HCI. The highest antibody dilution which allowed an observable color development was taken as the ELISA endpoint,
Enzyme-linked Immunosorbent Assay (ELISA)I :
The phenylenediamine solution was prepared by dissolving 2.5 mg of ophenylenediamine (Sigma Chemical Co.) in 0. l ml of methanol, to which were added 10 ml of 0.1 M phosphate buffer, pH 6.0. Prior to use, 1.6 ~1 of 50% hydrogen peroxide was added.
Tissue Preparation: Adult Sprague-Dawley rats were anesthestized with sodium pentobarbital (6.5 rag/100 g body wt) and perfused through the left ventricle, first briefly with 0.1 M sodium phosphate buffer (pH 7.4) containing 0.9% NaC1, and then with a solution containing 4% freshly prepared formaldehyde and 0. 1% glutaraldehyde in the same buffer. Rats from which retinas were obtained were peffused in three steps: (a) sodium phosphate buffer, pH 7.4, as above; (b) 4% freshly prepared formaldehyde and 0.1% glutaraldehyde in sodium phosphate buffer, pH 6.5; and (c) same aldehydes in sodium phosphate buffer, pH 11 (4) . The rats were perfused with ~ 1 ml of fixative per gram of body weight at a rate of 1-3 ml/min. Tissues of interest were removed and allowed to stand in fixative at room temperature for -1 h before being placed at 4"C overnight.
Immunofluorescence: Fixed tissue was sectioned to 15-~tm thickness with a Vibratome (Oxford Instruments Inc., Columbia, MD), or unfixed tissues were quick-frozen on dry ice and sectioned to 8 ~m with a microtome/eryostat, after which sections were mounted on gelatin-coated glass slides. The sections were covered with several drops of affinity-purified antibody solution (0.85 mg , and incubated for l h. After three 10-min washes with PBS, the sections were incubated with fluorescein isothiocyanate-conjugated goat lgG anti-rabbit F(ab')~ (Cappel Laboratories) diluted 800-fold with PBS. All incubations with antibodies were at room temperature in a humidified chamber. The sections were washed three times with PBS, and then for l0 min with 0.05 M Tris-buffered saline, pH 7.6. Sections were mounted under glass ¢overslips in 0. l M Tris-HCl buffer (pH 8.6) containing 50% glycerol.
Peroxidase-Antiperoxidase Staining : Fixed tissues were sectioned with an Oxford Vibratome to 15 or 20 tam thickness for light or electron microscopy, respectively. Sections were washed with agitation in five changes (10 rain each) of 0.1 M sodium phosphate buffer, pH 7.4. After a 30-rain incubation with agitation at room temperature in 3% normal swine serum (DAKO, Accurate Chemical and Scientific Corp.), the sections were transferred to a solution of affinity-purified antibodies at a concentration of 7 tag protein/ ml for light microscopy or 130 ~g protein/ml for electron microscopy. Dilutions were made in 0.05 M Tris-HCl buffer (pH 7.6) containing 0.9% NaCl and 1% normal swine serum. Control sections were incubated with F(ab')2 that was not adsorbed by the affinity column. Sections were incubated with the antibodies for 440 h at 4°C with agitation in a humidified chamber. They were then treated as follows: (a) warmed to room temperature for 2 h; (b) washed five times for l0 min each time with agitation in 0.05 M Tris-HO buffer (pH 7.6) containing 0.9% NaCl; (c) incubated with agitation for 30 min at room temperature with swine lgO anti-rabbit IgG (DAKO) diluted 50-fold with Tris-HCI buffer containing 1% normal swine serum; (d) washed five times for 10 min as in step (b); (e) incubated for 30 min at room temperature with a soluble horseradish peroxidase/anti-horseradish peroxidase complex (prepared in rabbits, DAKO) diluted 100-fold in buffer containing 1% normal swine serum; (J) washed five times for 10 rain; (g) incubated for 30 rain at room temperature with 0.05% 3,3'-diaminobenzidine and 0.01% hydrogen peroxide in Tris-HCl buffer; and (h) washed three times for l0 min in 0.1 M sodium phosphate buffer, pH 7.4.
Sections for light microscopy were mounted on gelatin-coated slides, dehydrated through a series of graded ethanols, cleared with xylene, sealed in Permount (Fisher Scientific Co., Pittsburgh, PA), and examined with a Leitz Ortholux microscope.
For electron microscopy, sections were fixed for l h with 1% osmium tetroxide in 0.1 M sodium phosphate buffer, pH 7.4, dehydrated through a series of graded ethanols, infiltrated with EPOX 812 (Ernest F. FuUam, Inc., Latham, NY), and embedded for thin-sectioning using either an LKB Ultrotome V or a Sorvall MT-5000 ultramicrotome (E. I. DuPont de Nemours & Co., Inc., Sorvall Instruments Div., Newton, CT). Tissue was generally not poststained except where specifically indicated, in which case 4% uranyl acetate in 50% methanol was used, followed by 0.2% lead citrate in distilled water. Grids were examined with a JEOL-100S electron microscope.
RESULTS

Characterization of Antibodies
Antibodies raised against the chondroitin sulfate proteoglycan were precipitated from serum, and F(ab')2 fragments were prepared and purified. The purification procedure resulted in an increase in titer of the affinity-purified F(ab')2 fragments of up to 86-fold as compared with the ammonium sulfate precipitated IgG.
The specificity of the antibodies was examined by double immunodiffusion, rocket immunoelectrophoresis, crossed immunoelectrophoresis, and ELISA. Since the antibody titer determined by ELISA plateaued at 5 wk after the initial immunization, rabbits were routinely bled-out at this time. When antibodies obtained 5 wk after the initial immunization were tested against the brain proteoglycan by double immunodiffusion, a single precipitin line resulted. One sharply defined rocket was seen after immunoelectrophoresis. Crossed immunoelectrophoresis also yielded a single rocket, indicating the monospecificity of the antibodies and the absence of antigenic components which are separable from the proteoglycan by electrophoresis (Fig. 1). (F(ab')2 fragments could rests of 3.3 #g of proteoglycan placed at the origin (asterisk) ran initially from left to right at 3 V/cm for 2 h, after which the direction was changed to run from bottom to top against IgG at 1 V/cm for 18h.
not be used for these immunoelectrophoretic studies, since they are less basic than IgG and therefore migrate under our conditions in the same direction as the proteoglycan.)
By ELISA it was shown that the antibodies could be diluted approximately 33,000-fold when assayed against the proteoglycan before a colorimetric endpoint was reached. Furthermore, this dilution is 100-1,000-fold greater than that required for an endpoint when the antibodies were assayed against other fractions obtained in the proteoglycan purification procedure, or against rat plasma proteins or the soluble proteins from whole brain.
When the proteoglycan (1.65 mg/ml) was digested for 1 h at room temperature with chondroitinase ABC (0.04 U/ml of 0.01 M PBS, pH 7.2, containing 0.1% Tween 20) and tested by the immunochemical assays described above, the chondroitinase-treated proteoglycan behaved identically to the native proteoglycan, except that sharper immunoprecipitin lines resulted after chondroitinase treatment. Although the immunochemical reactivity of chondroitin sulfate proteoglycans from cartilage is significantly increased following chondroitinase treatment, which facilitates access of the antibodies to antigenic sites on the protein core, our results are consistent with biochemical data indicating that the chondroitin sulfate polysaccharide chains are less densely spaced on the brain proteoglycan as compared with those of cartilage, and also indicate that the antibodies are not directed against the chondroitin sulfate chains.
Localization of the Proteoglycan
Since the cytoarchitecture of the cerebellum is well documented (35) , our studies of adult and immature brain (see following paper) have focused on this region. Other types of nervous and non-nervous tissues, including connective tissue, have also been examined. Our studies demonstrate that in adult rat brain the chondroitin sulfate proteoglycan is present intracellularly in neuronal and astroglial cytoplasm, whereas in early postnatal brain the proteoglycan is predominantly extracellular (primarily in the region of the presumptive white matter). During development there is a gradual shift in localFIou~ 2 Light micrographs of adult (a and b) and 7-d-old {c and d) rat cerebellum, stained by the peroxidase-antiperoxidase method. Although the proteoglycan is present throughout the adult cerebellum with the exception of Purkinje cells, the areas of heaviest staining are in the granule cell and molecular layers, and surrounding the Purkinje cell bodies. In the white matter, the axoplasm of some myelinated axons is stained while the myelin itself is unstained. At 7 d of postnatal age, heavy staining is present in the presumptive cerebel~ar white matter (most axons are not myelinated at this age) and in the molecular layer. Staining extends from the molecular layer to the external granule cell layer, decreasing significantly towards the pia. ization from extracellular to intracellular, and its intracellular appearance in astroglia precedes that in neurons (2) . A survey of adult rat tissues indicates that while some central nervous tissue elements stain specifically, there is no staining of peripheral nerve axons or sympathetic neurons. Additionally, some connective tissue elements stain in both nervous and non-nervous tissues, indicating the presence of certain similarities between the proteoglycans of nervous and connective tissues.
Nervous Tissue
The localization of the proteoglycan at the light microscopic level in adult and 7-d-old brain is shown in Fig. 2 . Results obtained by immunofluorescence staining (Fig. 3) demonstrate a staining pattern in adult brain similar to that seen using the peroxidase-antiperoxidase method.
An unusual finding which was most clearly revealed by electron miroscopy is the intracellular localization of the proteoglycan in the adult cerebellum, cerebrum, brain stem, and spinal cord (Figs. 4-11) . Specifically, granule cells of the cerebellum (Fig. 4) , cell bodies of cranial nerves located in the dorsal medulla (Fig. 5) , and astrocytes (including Golgi epithelial cells and Bergmann fibers; Figs. 6-8) all show strong cytoplasmic staining.
Although throughout the central nervous system there is heavy axoplasmic staining of both myelinated and unmyelinated axons, it is apparent that not all axons are stained (Figs. 9 and 10) . However, the axons of the granule cells (i.e., the parallel fibers) stain consistently (Fig. 11) . This is in agreement with the heavy staining observed at the light microscopic level since the parallel fibers make up the bulk of the molecular layer. Although nuclei generally do not stain, staining is seen in the nuclei of certain neurons (Figs. 4 and  12) . Consistent with the cytoplasmic localization of this proteoglycan in neurons and astroglia of the central nervous system is the intracellular staining which was observed in horizontal cells, ganglion cells, and MOiler cells of the retina (Figs. 12-14) . Bruch's membrane and the inner limiting membrane of the retina are also stained by antibodies to the chondroitin sulfate proteoglycan (Figs. 13 and 14) .
Several central nervous tissue elements are consistently unstained. Among these are Purkinje cells (Figs. 2, a and b, ( i.e., only the connective tissue septa stain, but not the chromaffin cells or chromafiin granules).
Connective and Other Non-nervous Tissues
Antibodies raised against the brain proteoglycan also crossreact to various degrees with the connective tissue and extracellular matrix of certain adult tissues. While the neural elements of sympathetic ganglion, sciatic nerve, and adrenal medulla do not stain, there is heavy staining of connective tissue. In the sympathetic ganglion (Figs. 15 and 16 ) and adrenal medulla and cortex, the supporting connective tissue septa stain. In sciatic nerve the Schwann cell basal lamina stains, as does the extracellular matrix surrounding the collagen fibrils, although the fibrils themselves do not stain (Fig.   17 ). 8, and 11), oligodendrocytes, myelin (Figs. 2, a and b, 9 , and 10), optic nerve axons, nerve endings (Fig. 10) , and synaptic vesicles (Fig. 10) . A mixed population of synaptic vesicles isolated from rat brain by the method of De Lorenzo and Freedman (13) was also examined and found not to stain. In axons where the axoplasm is stained next to the node of Ranvier, the nodal region (including the gap substance) remains unstained. Additionaly, we found no evidence for membrane and/or extracellular staining in adult central nervous tissue.
In sympathetic ganglion and sciatic nerve there is no staining of neuronal cell bodies, axons, myelin, or Schwann cells (Figs. 15-17) . However, the supporting connective tissue and certain components of the extracellular matrix are stained (see below). Adrenal medulla has a similar staining pattern as demonstrating the presence of extracellular glycosaminoglycans. These conclusions were further supported by Bondareff (7), who found similarly distributed material in tissue fixed by freezing and drying and stained with uranyl acetate. Castejrn and Castejrn (12) , employing the positively charged coordination compound of osmium and dimethylethylenediamine, Os-DMEDA (42), or Alcian blue with osmium tetroxide (GABOUL impregnation method; reference 3), demonstrated staining in mossy fiber rosettes of the presynaptic axoplasm, surrounding synaptic vesicles, continuous with presynaptic dense projections, and in the synaptic cleft. Results obtained after various enzymatic digestions (e.g., hyaluronidase, neuraminidase, ribonuclease) and carboxymethylation led the authors to conclude that the axoplasmic material of mossy fiber endings is a proteoglycan in which hyaluronic acid and chondroitin 4-and/or 6-sulfate are present.
There is no convincing evidence that the techniques employed by these investigators are specific for glycosaminoglycans, since they would be expected to stain any polyanionic macromolecule including nucleic acids, gbccoproteins (especially those containing sialic acid and/or ester sulfate residues), and possibly also gangliosides or acidic proteins. While enzymatic digestion studies provide additional information, they can also be misleading since "specific" glycosidase prep-FIGURE 7 Astrocyte similar to that seen in Fig. 6 , but incubated with control antibody that was not bound to the proteoglycan affinity column, x 38,000.
In hyaline cartilage of trachea, the lacunae and the surrounding connective tissue capsule are stained (Fig. 18) . (The absence of staining in the cartilage matrix is to be expected, since the sections were not treated with chondroitinase ABC to increase permeability to the antibody.) Other tissue components that were found to stain include the pia (Fig. 2 a) and the basement membrane ofchoroid plexus and kidney. There is no staining of spinal cord ependyma, liver, or skeletal muscle.
D I S C U S S I O N
There have been several earlier reports concerning the localization of glycosaminoglycans in nervous tissue using electron microscopy (6, 7, 12, 36, 45) . Pease demonstrated a uniform layer of phosphotungstic acid-staining material, which he identified as mucopolysaccharide (glycosaminoglycan), separating the pre-and postsynaptic elements of cerebral cortical synapses and in the larger extracellular spaces of the neuropil (36) . Studies by Bondareff (6) and Tani and Ametani (45) , employing ruthenium red with osmium tetroxide to stain anionic sites in the cerebral cortex, have also been interpreted arations are often contaminated with other glycosidases and proteases, a possibility that was not examined by these investigators. Moreover, the changes observed after enzyme treatment are often quite subtle and subjective. Although there are obviously also limitations in the use ofimmunocytochemical techniques, this method has been successfully employed for the localization of proteoglycans and related components of other tissues (23, 24, (39) (40) (41) .
Our immunocytochemical study has demonstrated the intracellular localization of a chondroitin sulfate proteoglycan in neurons and astroglia of central nervous tissue, findings that are consistent with those from previous work involving cellular and subcellular fractionation followed by biochemical analysis. Using these latter methods it has also been shown that this glycosaminoglycan is present in rat brain nuclei (26) and bulk-isolated axons (29) , but only in small amounts if at all in oligodendroglia (32), myelin, nerve endings and mitochondria (1, 29, 33, 43) . These results are all in good agreement with our present observations.
Although strong axoplasmic staining is present in some myelinated and unmyelinated axons, it is apparent that not all axons stain. This selective staining of certain neural elements is also seen in the case of nuclei and neuronal cell bodies. For example, cerebellar granule cells stain intracellulady, whereas Purkinje perikarya are unstained. Similarly, the cytoplasm of retinal ganglion and horizontal cells is stained, but there is no staining of amacrine cells, bipolar cells, or receptor cells (including rods and cones). The basis for this selectivity is not yet clear, but one possible explanation is simply that the proteoglycan is present only in certain cell types or subclasses. It is also possible that in those elements that appear unstained, the proteoglycan is present at a concentration below the limits of detection of our method.
It is known that sulfated glycosaminoglycans are transported in the fast component of axonal flow (for a review, see reference 15). At high magnification the proteoglycan staining observed in axons appears punctate and discrete, whereas staining of neuronal and astroglial cell bodies is more diffuse, less organized, and somewhat clumped. The staining pattern in axons suggests that the proteoglycan may be closely associated with microtubules, which are thought to play a role in axonal transport. However, it is also possible that this staining results from a "condensation" of the proteoglycan around microtubules during tissue processing.
Chondroitin sulfate and smaller amounts of heparan sulfate are present in adrenal chromaffin granules (17, 20, 31) , whereas synaptic vesicles isolated from marine electric organ have been reported (1 l, 44) to primarily contain a sulfated glycosaminoglycan resembling heparan sulfate (occurring in the form of a proteoglycan). We have, however, found no evidence indicating that antibodies to the chondroitin sulfate proteoglycan recognize any component of nerve endings, and
We have previously demonstrated the presence of chondroitin sulfate, together with smaller amounts of hyaluronic acid and heparan sulfate, in astrocyte-enriched fractions prepared from rat and bovine brain (32) . However, it should he noted that the chondroitin sulfate proteoglycan of brain that we have isolated and characterized (21) differs considerably from proteoglycans that are reported to be synthesized by "glia-½ke" cells cultivated from explants of normal human brain, and by cultured glial tumor cells of presumably astrocytic origin (l 8, 34). It is not surprising that the biochemical properties of these cultures are quite different from those of astrocytes (or oligodendroglia) isolated in bulk from normal brain, insofar as it is impossible to eliminate fibroblasts and endothelial cells (which would be expected to synthesize proteoglycans characteristic of connective tissue) from the explant cultures, and both the "glia-like" and giioma cells frequently lack glial fibrillary acidic protein and contain fibro-FIGURE 12 Nuclear and cytoplasmic staining of a horizontal cell of the retina, x 8,000.
FIGURE 13
Retinal ganglion cell (border indicated by arrows) whose nucleus is unstained whereas its cytoplasm stains intensely. The cytoplasm of a MOiler cell radial fiber (asterisk) is also stained, as is the internal limiting membrane. × 8,000.
ELISA studies showed no significant cross-reactivity with either the soluble fraction of bovine chromaffin granules or with large, dense-cored synaptic vesicles from splenic nerve (R. U. Margolis, R. L. Klein, and R. K. Margolis, unpublished results).
1126 THE JOURNAL OF CELL BIOLOGY • VOLUME 99, 1984 FIGURE 14 MOiler cell process adjacent to a blood vessel and terminating at the internal limiting membrane (arrows), which is partly composed of the basement membrane of the MLiller cell. The cytoplasm of the MOiler cell and the internal limiting membrane both stain heavily, x t0,000. nectin, which is not present in normal differentiated astrocytes (5, 37) .
Several studies (primarily of peripheral nerve) employing various heavy metal and polycationic stains have found predominantly two areas of staining at the node of Ranvier: over and/or in close proximity to the nodal axolemma, and filling the annular zone surrounding the nodal axolemma between Schwann cell fingers and bound externally by the Schwann cell basal lamina (i.e., the gap substance). It is suspected that the macromolecules involved in nodal staining are acidic glycoproteins containing sialic acid and/or glycosaminoglycans, particularly hyaluronic acid and chondroitin 4-or 6-sulfate (22) . These nodal areas, however, are not recognized by antibodies to the chondroitin sulfate proteoglycan in either the central or peripheral nervous system, although our antibodies do recognize the nodal axoplasm of those axons that stain in the central nervous system.
In sciatic nerve, Bunge and Bunge (8) postulated that normal differentiation of the Schwann cell and subsequent myelination require not only contact with nerve fibers, but also contact with a connective tissue matrix or some material associated with that matrix. It is quite possible that a proteoglycan identified by our antibodies, and which is present both in the basal lamina of Schwann cells and surrounding the collagen fibrils, may be involved in this recognition process. Evidence suggesting a similar association was presented by Ebendal (14) , and more recently by Carbonetto et al. (1 0) .
On the basis of a number of immunochemical and biochemical criteria, it would appear that our antibodies are monospecific for a chondroitin sulfate proteoglycan that has essentially the same size, charge, density, and chemical composition in both adult and immature brain (see following paper), and that these antibodies do not react with other brain proteins. PAGE of both the intact and chondroitinase-treated [35S]sulfate-labeled proteoglycans, followed by immunoblotting, in each case yielded broad and diffuse bands that were generally uninformative. However, all of the antibody binding coincided with [35S]sulfate-labeled gel regions (detected by fluorography), indicating that the antibody did not recognize other proteins. (In the case of chondroitinase-treated material, a significant portion of [3~S]sulfate radioactivity remains with sulfated glycoprotein oligosaccharides present in the chondroitin sulfate proteoglycan of brain [21 ] .) Therefore, though it is clear that our antibodies are specific for a chondroitin sulfate proteoglycan, it is possible that this specificity extends to a number of closely related species that are indistinguishable by the biochemical and immunochemical analyses used in our studies, and some heterogeneity of this type would even appear very likely in view of the known polydispersity of proteoglycans.
It was not unexpected that the antibodies used in this study also stain components of connective and other non-nervous tissues, where staining is generally present in basement membranes or associated with collagen fibrils. For example, the basement membranes of retinal pigment epithelium and the choriocapillaris (components of Bruch's membrane) and the basement membrane of MOiler cells (a component of the internal limiting membrane of retina) all stain. These membrane structures also contain collagen fibrils. In addition to the retina, basement membrane staining was seen in Schwann cells, choroid plexus, and kidney. Although in brain these antibodies are specific for a chondroitin sulfate proteoglycan, Aquino, and R. U. Margolis, unpublished results). In these studies, antibodies raised against the brain proteoglycan were found to react strongly with bovine nasal septum proteoglycan, weakly with bovine articular cartilage and epiphyseal proteoglycans and rat chondrosarcoma link protein, and not at all with bovine growth plate proteoglycan. Additionally, antibodies raised against bovine articular cartilage proteoglycan and rat chondrosarcoma link protein react with the brain proteoglycan. These results are consistent with the staining of certain connective tissue elements observed in our immunocytochemical studies.
